MoneyWorks4Me

Themis Medicare - Quaterly Results

13 May 2023 Evaluate
A minor change in the total revenue was seen in the March 2023 quarter. The total revenue for the quarter stood at Rs. 801.05 millions against Rs. 797.97 millions during year ago period.The Company's Net profit for the March 2023 quarter have declined marginally to Rs. 60.42  millions as against Rs. 75.51 millions reported during the corresponding quarter ended.The company reported a degrowth in operating Profit to 134.33 millions from 162.62 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 801.05 797.97 0.39 3543.23 3946.14 -10.21 3543.23 3946.14 -10.21
Other Income 29.47 18.38 60.34 115.05 65.41 75.89 115.05 65.41 75.89
PBIDT 134.33 162.62 -17.40 789.67 1021.92 -22.73 789.67 1021.92 -22.73
Interest 27.08 19.28 40.46 95.64 87.74 9.00 95.64 87.74 9.00
PBDT 107.25 143.34 -25.18 694.03 934.18 -25.71 694.03 934.18 -25.71
Depreciation 27.96 23.89 17.04 104.95 94.80 10.71 104.95 94.80 10.71
PBT 79.29 119.45 -33.62 589.08 839.38 -29.82 589.08 839.38 -29.82
TAX 18.87 43.94 -57.06 156.14 223.81 -30.24 156.14 223.81 -30.24
Deferred Tax 3.87 13.94 -72.24 6.14 56.31 -89.10 6.14 56.31 -89.10
PAT 60.42 75.51 -19.98 432.94 615.57 -29.67 432.94 615.57 -29.67
Equity 92.00 92.00 0.00 92.03 92.00 0.03 92.03 92.00 0.03
PBIDTM(%) 16.77 20.38 -17.71 22.29 25.90 -13.94 22.29 25.90 -13.94
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..